July 15, 2014Journal of HepatologyOpen Access

CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis

View Full Paper

Ask AI

Bookmark

Abstract

We demonstrate for the first time that CXCL10 plays a pivotal role in the pathogenesis of experimental steatohepatitis. CXCL10 maybe a potential non-invasive biomarker for NASH patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhang et al. (2014) studied this question.

synapsesocial.com/papers/69de9e53741e97d2d4e93fac https://doi.org/10.1016/j.jhep.2014.07.006

View Full Paper

Ask AI

Bookmark

Abstract

We demonstrate for the first time that CXCL10 plays a pivotal role in the pathogenesis of experimental steatohepatitis. CXCL10 maybe a potential non-invasive biomarker for NASH patients.